AsiaMedic
To make an appointment, call: (65) 6789 8888

Email This Print ThisNews

Change - Announcement Of Resignation Of Chief Executive Officer

BackJan 03, 2019
Announcement Title Change - Announcement of Cessation
Date & Time of Broadcast Jan 3, 2019 20:07
Status New
Announcement Sub Title RESIGNATION OF CHIEF EXECUTIVE OFFICER
Announcement Reference SG190103OTHR2GBT
Submitted By (Co./ Ind. Name) Stanley Woo
Designation Group Financial Controller
Description (Please provide a detailed description of the event in the box below)
This announcement has been prepared by the Company and reviewed by the Company's sponsor, Xandar Capital Pte Ltd (the "Sponsor"), for compliance with the Listing Manual (Section B: Rules of Catalist) of the Singapore Exchange Securities Trading Limited (the "SGX-ST"). The Sponsor has not independently verified the contents of this announcement including the accuracy or completeness of any of the information disclosed or the correctness of any of the statements made, opinions expressed or reports contained in this announcement. This announcement has not been examined or approved by the SGX-ST. The SGX-ST and the Sponsor assume no responsibility for the contents of this announcement including the correctness of any of the statements made, opinions expressed or reports contained in this announcement.

Contact person for the Sponsor: Ms Pauline Sim (Registered Professional, Xandar Capital Pte Ltd)
Address: 3 Shenton Way, #24-02 Shenton House, Singapore 068805
Telephone number: (65) 6319 4954
Additional Details
Name Of Person Choo Kin Poo
Age 44
Is effective date of cessation known? Yes
If yes, please provide the date 01/04/2019
Detailed Reason (s) for cessation Resigned to pursue personal interests.

The Company's sponsor, Xandar Capital Pte Ltd, has interviewed Mr Choo and is satisfied that, other than the reason as disclosed above, there are no material reasons for his resignation.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? No
Any other relevant information to be provided to shareholders of the listed issuer? No
Date of Appointment to current position 13/06/2016
Does the AC have a minimum of 3 members (taking into account this cessation)? Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation) 2
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months 3
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) Chief Executive Officer
Role and responsibilities Role of Chief Executive Officer reporting to the Board of Directors. Responsible for carrying out the strategies and policies as established by the Board and for the overall management, development and financial performance of the Group.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries No
Shareholding interest in the listed issuer and its subsidiaries? Yes
Shareholding Details Indirect interest of 54,900 ordinary shares in AsiaMedic Limited
Past (for the last 5 years) Please refer to the attachment
Present Please refer to the attachment

Attachments

  1. Attachment 1 (Size: 2,426 bytes)